L

Standard BioTools
D

LAB

1.72000
USD
0.10
(5.85%)
Market Closed
Volume
91,895
EPS
-0
Div Yield
-
P/E
-2
Market Cap
640,285,133
News

Title: Standard BioTools

Sector: Healthcare
Industry: Medical Devices
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.